IG Financial Facts
Operating loss: 303KProduct development and research expenses: 4.02M
See Full Income Statement
Additional paid-in capital: 101.74M
Total liabilities: 125.47M
See Full Balance Sheet
IGI Laboratories, Inc. (IG) Earnings
|
Expand Research on IG
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +25.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/15  |
Q315 | $0.00 | -$0.05 | +$0.05 | $11.6M | $9.36M | = |  | | Details | |
| 7/23/15 |
 |
Q215 | -$0.04 | -$0.08 | +$0.04 | $8.9M | $7.63M | = | | | Details |
| 4/28/15 |
|
Q115 | $0.00 | $0.01 | -$0.01 | $10.7M | $12.32M | = | | | Details |
| 3/2/15 |
|
Q414 | $0.09 | $0.06 | +$0.03 | $13.7M | $11.88M | = | | | Details |
| 10/23/14 | Q314 | $0.00 | -$0.01 | +$0.01 | $6.7M | $6.33M | N/A | | | Details | |
| 4/29/14 | Q114 | $0.00 | $0.01 | -$0.01 | $6.9M | $6.02M | N/A | | | Details | |
| 10/29/13 |
|
Q313 | $0.00 | N/A | N/A | $4M | $1.99M | N/A | | | Details |
| 11/13/12 |
Q312 | -$0.04 | N/A | N/A | $1.98M | $2.11M | N/A | | | Details |
